Background: VEGF blockade coupled with cytotoxic chemotherapy can promote an immune-permissive tumor microenvironment that can augment response to PD-L1 inhibition. IMbrave151 (NCT04677504) is a ...

Gemcitabine chemotherapy is used for advanced cancers of the breast, lungs, ovaries, and pancreas. Learn about delivery, side effects, effectiveness, and more.

In a phase 1–2 trial of albumin-bound paclitaxel (nab-paclitaxel) plus gemcitabine, substantial clinical activity was noted in patients with advanced pancreatic cancer. We conducted a phase 3 ...

Gemcitabine has been used since 1997 as a treatment for advanced unresectable pancreatic cancer, and it is a potent radiosensitizer. Dr. Loehrer and colleagues examined the role, among patients ...

Prior to induction BCG, the gemcitabine-docetaxel group had a significantly higher proportion of patients with Ta/Tis (noninvasive) tumors compared with the BCG group (68.8% vs 52.2%), whereas the ...

Yes. The randomized phase 3 APACT trial was a well-designed adjuvant trial that evaluated the addition of nab-paclitaxel (Abraxane, Celgene) to gemcitabine — the combination was planned based ...

After a median follow-up of 8.2 months and 327 deaths, the median overall survival was 11.7 months among the 204 patients in the cisplatin–gemcitabine group and 8.1 months among the 206 patients ...

A patient who is receiving cisplatin and gemcitabine in 2 cycles for nonsmall-cell lung cancer (NSCLC) developed thrombocytosis (platelet count 800,000/mcL). There are no other side effects. Is it ...

Data presented at the 13th European Conference (ECCO) revealed that using the combination of gemcitabine and capecitabine increased overall survival in some patients. Skip to main content.

We report our experience with sequential intravesical combination chemotherapy using gemcitabine and mitomycin C (MMC) for non-muscle invasive bladder cancer (NMIBC). Methods: We performed a ...

In January 2011, Teva Pharmaceuticals USA, Inc. received approval and APP Pharmaceuticals launched Gemcitabine HCI for Injection in the 200 mg and 1g dosage forms as part of a commercialization ...